Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...

Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.

A single eye just became ground zero for one of science's biggest bets on turning back the clock on aging. Boston-based Life ...

For decades, a diagnosis of glioblastoma – an aggressive, hard-to-treat cancer in the brain – has been a death sentence for patients. Only 3% to 5% of people who are diagnosed with this type of brain ...